Celltex Muscles Ethics Professor For Contacting FDA
By Ed Silverman,
Pharmalot
| 03. 12. 2012
Over the past month, a controversy erupted involving a stem cell company called Celltex Therapeutics and a newly hired executive, Glenn McGee. The issue centered on the confusing circumstances in which he was listed as the editor-in-chief of a bioethics journal at the same time that he began his job at Celltex, which has ties to a controversial stem cell company in South Korea called RNL Bio (
see this).
Celltex Therapeutics - which was co-founded by Stan Jones, the same surgeon who treated Texas Governor Rick Perry for back pain with unapproved adult stem cells - has a partnership deal with RNL Bio. And RNL Bio, which has marketed its stem cell treatments in various countries, made headlines nearly two years ago after patient deaths were reported in China and Japan. The International Cellular Medicine Society conducted a review, co-headed by McGee, which largely exonerated RNL.
This thorny episode, which prompted McGee to resign from Celltex (
look here), was chronicled by a pair of bioethics professors at the University of Minnesota, both of whom have now...
Related Articles
By Oscar Lopez, The Guardian | 07.19.2026
Diogo Amaro met his future husband, Loup, in Paris and from the first date, he made one thing clear: he wanted to have children.
“Right off the bat, I was like: ‘If I’m going to be in a relationship with...
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...
The title of this book is clever, not least because it is borrowed from a very secret society of a dozen Stanford students. Theo Baker, a gregarious computer science freshman, was interviewed by the hyper-rich anonymous entrepreneur who quietly assembled the members. The unspoken suggestion was that he might consider hiring some of the members in service of acquiring his next billion. (Either Baker was not offered a place or he is not admitting it.) Such are the ways of...